DAFNA Capital Management’s Cogentix Medical, Inc. CGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-310,382
Closed -$1.2M 89
2018
Q1
$1.2M Sell
310,382
-13,100
-4% -$41K 0.58% 47
2017
Q4
$1.02M Hold
323,482
0.55% 52
2017
Q3
$828K Sell
323,482
-30,000
-8% -$65.7K 0.51% 50
2017
Q2
$615K Hold
353,482
0.44% 52
2017
Q1
$636K Hold
353,482
0.54% 52
2016
Q4
$710K Hold
353,482
0.62% 46
2016
Q3
$643K Buy
353,482
+600
+0.2% +$776 0.45% 52
2016
Q2
$339K Hold
352,882
0.27% 68
2016
Q1
$388K Buy
352,882
+1,101
+0.3% +$1.24K 0.33% 72
2015
Q4
$454K Hold
351,781
0.4% 58
2015
Q3
$436K Sell
351,781
-1,400
-0.4% -$2.15K 0.43% 59
2015
Q2
$572K Buy
+353,181
New +$578K 0.48% 49

DAFNA Capital Management's CGNT Position: Q2 2018 in Review

DAFNA Capital Management sold out of Cogentix Medical, Inc. (CGNT) in Q2 2018, closing a stake of 310,382 shares — an estimated $1.2M sold.

DAFNA Capital Management first reported a position in CGNT in Q2 2015 and held it in 12 quarters. The position peaked at $1.2M in Q1 2018. 0 funds tracked by Wall St. Rank hold CGNT as of Q2 2018.

  • DAFNA Capital Management reported no remaining Cogentix Medical, Inc. position as of Q2 2018 after selling out during the quarter.
  • DAFNA Capital Management sold 310,382 Cogentix Medical, Inc. shares in Q2 2018, an estimated $1.2M.
  • DAFNA Capital Management first reported a position in Cogentix Medical, Inc. in Q2 2015 and held it in 12 quarters.
  • DAFNA Capital Management's Cogentix Medical, Inc. position peaked at $1.2M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2018.

Based on DAFNA Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.